|
"Oncorequisite" Genes in MYC-mediated Transformation
|
5R00CA134743-04
|
$245,188
|
Feng, Hui
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Acidic Phospholipid-Selective Treatment for Neuroblastoma
|
5R01CA158372-03
|
$305,799
|
QI, XIAOYANG
|
UNIVERSITY OF CINCINNATI
|
|
ANTICANCER DRUG DISCOVERY THAT TARGETS TUMOR HYPOXIA
|
5R01CA098787-09
|
$246,402
|
NAGLE, DALE
|
UNIVERSITY OF MISSISSIPPI
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-24
|
$486,165
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S1
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S2
|
$43,265
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-07
|
$3,092,811
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-12S1
|
$125,000
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-12
|
$692,608
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Berberine downregulates MDM2 by interaction with DAXX in cancer cells
|
5R01CA143107-04
|
$293,258
|
ZHOU, MUXIANG
|
EMORY UNIVERSITY
|
|
BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA
|
ZIA BC 011002
|
$92,660
|
Khan, Javed
|
CCR (NCI)
|
|
Biology and Therapy of High Risk Neuroblastoma
|
5P01CA081403-14
|
$1,876,546
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$336,277
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA006516-48S1
|
$114,538
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-48S3
|
$12,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-48S4
|
$50,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA006516-48
|
$10,435,722
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA008748-47S4
|
$12,328,495
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RES
|
|
Cancer Center Support Grant
|
3P30CA008748-47S5
|
$18,456
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RES
|
|
Cancer Center Support Grant
|
3P30CA008748-47S6
|
$238,405
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RES
|
|
Cancer Center Support Grant
|
3P30CA082103-15S1
|
$74,881
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA082103-15
|
$7,004,044
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-34S4
|
$5,527,034
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-34S5
|
$50,000
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-34S6
|
$31,250
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Center for Environment-Mediated Drug Resistance in Pediatric Cancer
|
5U54CA163117-03
|
$456,366
|
DeClerck, Yves
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-19
|
$3,978,213
|
Robison, Leslie
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-11
|
$24,894,951
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-11
|
$5,797,460
|
ANDERSON, JAMES
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Clinical Development of HU14.18-IL2 Targeted Therapy
|
5R01CA032685-29
|
$292,778
|
SONDEL, PAUL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
ZIA SC 010354
|
$482,920
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Columbia University Medical Center Minority-Based Community Clinical Oncology Pro
|
5U10CA167791-02
|
$796,302
|
KELLY, KARA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Combination immunotherapy for neuroblastoma: model of innate tumor immunity
|
5R01CA164365-02
|
$343,969
|
HSU, KATHARINE
|
SLOAN-KETTERING INST CAN RES
|
|
Combination therapy to inhibit neuroblastoma growth
|
5R01CA147792-04
|
$334,173
|
Gondi, Christopher
|
UNIVERSITY OF ILLINOIS
|
|
Community Clinical Oncology Program Research Base
|
5U10CA095861-12
|
$1,884,051
|
POLLOCK, BRAD
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Community Clinical Oncology Program: FL Pediatric CCOP
|
5U10CA035157-30
|
$503,765
|
TALBERT, JAMES
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
Comparative Genomic Hybridization of Neuroblastoma
|
ZIA BC 010592
|
$69,495
|
Khan, Javed
|
CCR (NCI)
|
|
Copy number variations (CNVs) in neuroblastoma
|
5R00CA151869-04
|
$228,468
|
Diskin, Sharon
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Delaware/Christiana Care Community Clinical Oncology Program
|
5U10CA045418-27
|
$1,543,934
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Development and Excecution of Collaborative High-Throughput Microscopy Assays
|
ZIC BC 011453
|
$483,177
|
Voss, Ty
|
CCR (NCI)
|
|
Duluth Community Clinical Oncology Program
|
5U10CA035269-30
|
$770,073
|
Nikcevich, Daniel
|
ESSENTIA INSTITUTE OF RURAL HEALTH
|
|
Engineering and Evaluation of Human L-Methionase for Cancer Therapy
|
5R01CA154754-03
|
$403,071
|
GEORGIOU, GEORGE
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
EORTC HEADQUARTERS
|
4U10CA011488-43
|
$250,025
|
Lacombe, Denis
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Geisinger Clinical Oncology Program
|
3U10CA035448-29S1
|
$498,395
|
Gorak, Edward
|
GEISINGER CLINIC
|
|
Gene-Product Auto-Targeting to Tumor Vessels
|
5R01CA120895-07
|
$273,722
|
LI, SHULIN
|
UT MD ANDERSON CANCER CTR
|
|
GHSU Minority-Based Community Clinical Oncology Program
|
5U10CA107586-10
|
$480,324
|
Ghamande, Sharad
|
GEORGIA REGENTS UNIVERSITY
|
|
GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM
|
5U10CA035178-30
|
$1,417,905
|
Padula, Gilbert
|
SPECTRUM HEALTH HOSPITALS
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
5U10CA063844-20
|
$736,823
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Identification of Genes for Predicting Prognosis in Pediatric Cancers
|
ZIA SC 010366
|
$231,649
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$949,760
|
Khan, Javed
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|